TipRanks
Advertisement
Advertisement

DE:I5X Stock Latest News

Precigen initiated with a Buy at B. Riley
The FlyPrecigen initiated with a Buy at B. Riley
14d ago
PGEN
Precigen initiated with a Buy at B. Riley
PremiumThe Fly
Precigen initiated with a Buy at B. Riley
14d ago
PGEN
FDA Platform Designation Strengthens AdenoVerse Outlook; Analyst Maintains Buy Rating and $18 Price Target on Precigen
PremiumRatings
FDA Platform Designation Strengthens AdenoVerse Outlook; Analyst Maintains Buy Rating and $18 Price Target on Precigen
18d ago
PGEN
Precigen says FDA grants platform technology designation to AdenoVerse platform
PremiumThe Fly
Precigen says FDA grants platform technology designation to AdenoVerse platform
18d ago
PGEN
Precigen Q2 marked commercial inflection
PremiumThe Fly
Precigen Q2 marked commercial inflection
1M ago
PGEN
Precigen Rides PAPZIMEOS Surge to Early Profitability
PremiumCompany AnnouncementsPrecigen Rides PAPZIMEOS Surge to Early Profitability
2M ago
PGEN
Precigen’s CEO Trading Plan Changes Stir Investor Concerns Over Governance and Insider Confidence
Premium
Company Announcements
Precigen’s CEO Trading Plan Changes Stir Investor Concerns Over Governance and Insider Confidence
2M ago
PGEN
Precigen price target raised to $18 from $14 at H.C. Wainwright
Premium
The Fly
Precigen price target raised to $18 from $14 at H.C. Wainwright
2M ago
PGEN
Precigen reports Q2 EPS 5c vs., (9c) last year
PremiumThe Fly
Precigen reports Q2 EPS 5c vs., (9c) last year
2M ago
PGEN
Precigen options imply 11.1% move in share price post-earnings
PremiumThe Fly
Precigen options imply 11.1% move in share price post-earnings
2M ago
PGEN
Precigen, Inc. (PGEN) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Precigen, Inc. (PGEN) Q2 Earnings Cheat Sheet
2M ago
PGEN
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance
PremiumCompany Announcements
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance
4M ago
8K
PGEN
Precigen presents long-term follow-up data from study of Papzimeos
PremiumThe FlyPrecigen presents long-term follow-up data from study of Papzimeos
4M ago
PGEN
Precigen price target raised to $14 from $11 at H.C. Wainwright
Premium
The Fly
Precigen price target raised to $14 from $11 at H.C. Wainwright
4M ago
PGEN
Precigen receives orphan drug exclusivity for papzimeos in the U.S.
Premium
The Fly
Precigen receives orphan drug exclusivity for papzimeos in the U.S.
4M ago
PGEN
Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue
PremiumCompany Announcements
Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue
5M ago
PGEN
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
PremiumCompany Announcements
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
5M ago
PGEN
Precigen price target raised to $11 from $10 at H.C. Wainwright
PremiumThe Fly
Precigen price target raised to $11 from $10 at H.C. Wainwright
5M ago
PGEN
Precigen price target raised to $11 from $9 at Citizens
PremiumThe Fly
Precigen price target raised to $11 from $9 at Citizens
5M ago
PGEN
Precigen reports Q1 EPS (2c) vs. (18c) last year
PremiumThe FlyPrecigen reports Q1 EPS (2c) vs. (18c) last year
5M ago
PGEN
Precigen, Inc. (PGEN) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Precigen, Inc. (PGEN) Q1 Earnings Cheat Sheet
5M ago
PGEN
Midday Fly By: Health insurers get ‘positive surprise’ from CMS
Premium
The Fly
Midday Fly By: Health insurers get ‘positive surprise’ from CMS
6M ago
CI
EL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >